US76029N1063
US76029N1063
Replimune Group, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2026 | 2025 | Change % |
|---|---|---|---|
| Total Revenue | -- | -- | -- |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 318.315.000 | 259.854.000 | 22.5% | |
| Operating Income | -318.315.000 | -259.854.000 | 22.5% |
| Pretax Income | -314.491.000 | -246.829.000 | 27.4% |
| Net Income Common Stockholders | -313.940.000 | -247.297.000 | 26.9% |
| -- | -- | -- | |
| -- | -- | -- |